MedPath

The GRADE Capillary Blood Collection Pilot Study

Completed
Conditions
Type 2 Diabetes
Registration Number
NCT02388100
Lead Sponsor
GRADE Study Group
Brief Summary

This pilot study is planned to validate the comparability of HbA1c results obtained from whole blood collection via venous phlebotomy versus a capillary collection of whole blood. The participant will self-collect capillary blood into HbA1c prep vials containing a buffer; these prep vials will be sent to the CBL at ambient temperature via US Postal System (USPS) mail. The feasibility of self-collection of these capillary samples by GRADE participants will also be evaluated.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Current GRADE participant with a scheduled follow-up visit
Exclusion Criteria
  • GRADE participants attending first quarterly (Month 3) visit or an annual visit

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HbA1c obtained from venous versus capillary measurements at one point in time for each participant.Cross sectional
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (5)

Pennington Biomedical Research Center

🇺🇸

Baton Rouge, Louisiana, United States

International Diabetes Center

🇺🇸

Minneapolis, Minnesota, United States

Pacific Health Research and Education Institute (VA Pacific Islands)

🇺🇸

Honolulu, Hawaii, United States

Southwestern American Indian Center

🇺🇸

Phoenix, Arizona, United States

University of Colorado

🇺🇸

Denver, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath